Castle Biosciences’ new data presented at ACG 2026 show the TissueCypher test offers objective risk stratification for Barrett’s esophagus progression, providing information beyond standard histopathology.
The AI-powered pathology tool becomes the first AI-based drug development tool to receive FDA qualification, following earlier EMA approval.
PreciseDx's study demonstrates that their platform for assessing risk of recurrence of breast cancer can reduce costs and improve care.
Researchers used deep learning framework to transform microscopy images of intact skin into histochemically stained sections imaged on microscope slides.
Read More
The 10x Genomics Visium for FFPE assay kit contains all the reagents and consumables needed for whole transcriptome analysis in entire human FFPE tissue sections.
Read More
Acquiring Mosaic further strengthens the North American base for Caprion-HistoGeneX’s histopathology assay development and deployment and expands the volume of pathology services.
Read MoreThe SeqPack Hybridoma Preservation Kit streamlines the sample submission process for hybridoma sequencing customers, with no dry ice transport needed.
Read More
Doctors believe elevated ferritin levels are a marker for the rapid deterioration of some covid-19 patients and that early detection could save lives.
Read More
The patents are for using AI and image analysis to quantify staining quality in tissue sections stained with IHC- or ISH-based tissue biomarkers.
Read MoreThe IVD-grade TIGIT antibody for immunohistochemistry clinical application is available in a concentrate format as well as a ready-to-use predilute format.
Read More
The SCP-R is designed for use in pathology and histology labs to print high-resolution text, graphics, and bar codes directly onto tissue cassettes.
Read MoreCodex technology combines the advantages of single-cell biology with histology at single-cell spatial resolution.
Read More
The company’s latest light microscopy units feature high-quality complementary metal oxide semiconductor cameras to support digital imaging.
Read MoreClearLight will combine the new Crystal technology with its Clarity automated lipid-clearing platform.
Read More
AI-driven digital pathology can accelerate cancer diagnosis and clinical trial recruitment.
Read More
Discovery by Medical University of Vienna research team may lead to early identification of dangerous complications among transplant patients.
Read More
Monitoring cancer therapy in real time enables physicians to make smarter treatment decisions.
Read More
The May 2019 Product Spotlight includes anatomic and digital pathology instruments and analyzers from companies such as OptraScan, Proscia, and BioGenex Laboratories.
Read More